Hundreds of cold chain workers are feared to be re-victimized after being forced to push vaccines in Tianjin

On Dec 15, netizens revealed that employees of a cold-chain food company in Tianjin have started to promote the COVID-19 vaccine, saying that employees who get vaccinated will not have to undergo weekly nucleic acid tests. Earlier, it was reported that about 300 of the more than 400 employees sent to Serbia by Tianjin Power Construction Company have been confirmed to be infected, even though they had been vaccinated with the COVID-19 vaccine.

According to a video posted by Internet users, people in Shuanggang Town, Jinnan District, Tianjin municipality, began receiving emergency COVID-19 vaccinations on Dec 15, starting with employees working on cold-chain food products. A second injection after a one-month interval is charged at $450. It is reported that after the vaccine, these employees will not have weekly nucleic acid tests.

The current dose of inactivated vaccine used in Tianjin is 0.5 milliliters, according to official information. Within 24 hours of inoculation, pain, redness, itching, irritability and even “rare” adverse reactions may occur at the injection site.

The vaccination is voluntary and the age limit is between 18 and 59. Vaccination is not recommended for people with chronic diseases, allergies, or breastfeeding.

According to Freedom Asia, about 300 of the more than 400 employees of Tianjin Electric Power Construction Company in a project department in Serbia have been confirmed. These included a large number of Chinese employees who had been vaccinated against the COVID-19 vaccine but were still infected.

It is reported that the migrant workers are required to have domestic vaccines first, otherwise they will not be allowed to go abroad.

On December 11th at least 17 Chinese were reported to have been infected in Angola, 16 of them employees of a State-owned Chinese company in Lunda Norte province, who had been vaccinated against the national medicine before going abroad.

Recently, there have been many problems with China’s COVID-19 vaccine. On December 12, the phase III clinical trial in Peru was suspended because of problems with participants. On Dec. 15, Brazil’s health regulator criticized China for its opaque vaccine standards.

But it was previously reported that more than 90 percent of medical workers in Shanghai refused to receive China’s COVID-19 vaccine, after a survey of high-risk workers found that people trusted it. Because they know that Chinese vaccines do not have phase III clinical risk.